Daxor Corporation Common Stock (DXR) Stock Price

DXRStock

$10.05−18.14%52W

Market Cap$58.67M

P/E6.80x

PEG Ratio—

Div yield—

Beta0.39

DXR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-7.67%

Price vs S&P 500 (4W)-8.78%

VGM Score43.62

P/E Ratio (Annual)6.80x

P/CF (Annual)109.28x

Book Value / Share (Quarterly)$8.88

P/TBV (Annual)2.05x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-51.22%

Cash Flow / Share (Quarterly)$-1.40

Price vs S&P 500 (YTD)-42.12%

Gross Margin (TTM)-5771.14%

Net Profit Margin (TTM)19861.42%

EPS (TTM)$1.52

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$1.52

Revenue Growth (5Y)-36.57%

EPS (Annual)$1.81

ROI (Annual)19.98%

Gross Margin (Annual)-3917.23%

Net Profit Margin (5Y Avg)7784.99%

Cash / Share (Quarterly)$0.02

P/E Basic Excl Extra (TTM)10.02x

Revenue Growth QoQ (YoY)25.45%

P/E Normalized (Annual)6.80x

ROA (Last FY)19.93%

Revenue Growth TTM (YoY)-52.71%

EBITD / Share (TTM)$-0.35

ROE (5Y Avg)12.52%

Operating Margin (TTM)-6043.34%

Cash Flow / Share (Annual)$0.11

P/B Ratio1.20x

P/B Ratio (Quarterly)1.16x

EV / Revenue (TTM)1989.60x

Net Interest Coverage (TTM)-0.38x

ROA (TTM)12.73%

EPS Growth QoQ (YoY)329.99%

EV / EBITDA (TTM)6239.39x

EPS Incl Extra (Annual)$1.81

Current Ratio (Annual)0.08x

Quick Ratio (Quarterly)2.88x

3-Month Avg Trading Volume0.01M

52-Week Price Return-18.14%

EV / Free Cash Flow (Annual)109.28x

P/E Incl Extra (TTM)10.02x

Tangible BV / Share (Quarterly)$6.33

P/S Ratio (Annual)2337.73x

Asset Turnover (Annual)0.00x

52-Week High$14.76

Operating Margin (5Y Avg)-1352.68%

EPS Excl Extra (Annual)$1.81

Tangible BV CAGR (5Y)16.06%

26-Week Price Return2.24%

Quick Ratio (Annual)0.08x

13-Week Price Return-0.59%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.88x

Enterprise Value$62.39M

Revenue / Share Growth (5Y)-39.61%

Asset Turnover (TTM)0.00x

Book Value / Share Growth (5Y)18.24%

Inventory Turnover (Annual)1.86x

Pretax Margin (Annual)34356.58%

Cash / Share (Annual)$0.02

3-Month Return Std Dev46.24%

Gross Margin (5Y Avg)-1212.70%

ROE (Last FY)19.98%

Net Interest Coverage (Annual)-0.48x

EPS Basic Excl Extra (Annual)$1.81

P/FCF (TTM)109.28x

Receivables Turnover (TTM)7.25x

EV / Free Cash Flow (TTM)113.71x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$1.52

Receivables Turnover (Annual)7.25x

ROI (TTM)12.75%

P/S Ratio (TTM)1989.60x

Pretax Margin (5Y Avg)7784.99%

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$7.15

Free OCF CAGR (5Y)-61.68%

Price vs S&P 500 (52W)-27.70%

P/E Ratio (TTM)10.02x

EPS Growth TTM (YoY)272.87%

Year-to-Date Return-31.86%

5-Day Price Return-2.47%

EPS Normalized (Annual)$1.81

ROA (5Y Avg)11.66%

Net Profit Margin (Annual)34356.58%

Month-to-Date Return-10.67%

EBITD / Share (Annual)$-0.22

EPS Growth (3Y)14.49%

Operating Margin (Annual)-4207.38%

LT Debt / Equity (Annual)0.01x

P/CF (TTM)113.71x

ROI (5Y Avg)11.81%

P/E Excl Extra (TTM)10.02x

LT Debt / Equity (Quarterly)0.01x

EPS Basic Excl Extra (TTM)$1.52

P/TBV (Quarterly)1.25x

P/B Ratio (Annual)1.59x

Inventory Turnover (TTM)1.89x

Pretax Margin (TTM)19861.42%

Book Value / Share (Annual)$9.07

Price vs S&P 500 (13W)-3.28%

Beta0.39x

P/FCF (Annual)109.28x

Revenue / Share (TTM)$0.01

ROE (TTM)12.75%

52-Week Low$8.56

vGradeD

gGradeC

mGradeC

vgmGradeC

DXR Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
DXRDaxor Corporation Common Stock	D	C	C	1989.6x	-36.6%	-5771.1%	-6043.3%	$10.05
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Daxor Corporation Common Stock

Daxor Corp is a medical instrumentation company specializing in blood volume diagnostics. The company develops and markets the BVA-100 (Blood Volume Analyzer), an FDA-cleared diagnostic tool that provides accurate, objective measurement of blood volume status and composition across a broad range of medical conditions. By comparing results to patient-specific norms, the BVA-100 enables clinicians to make data-driven treatment decisions.